Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.69 USD | -3.35% |
|
+22.69% | +25.74% |
06-24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
06-13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.74% | 679M | |
+24.46% | 47.96B | |
+0.03% | 42.45B | |
+43.96% | 41.47B | |
+26.34% | 31.6B | |
+19.27% | 28.63B | |
-4.47% | 28.03B | |
+51.66% | 14.56B | |
+43.83% | 14.14B | |
+2.09% | 12.58B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07